Infectious Diseases
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-TNF antibody (141-190 aa) (STJ96054) | Anmelden | Anti-TNF antibody (141-190 aa) (STJ96054) | ||||||||||||||||
|
||||||||||||||||||
| Anti-MPHOSPH10 antibody (60-140 aa) (STJ96444) | Anmelden | Anti-MPHOSPH10 antibody (60-140 aa) (STJ96444) | ||||||||||||||||
|
||||||||||||||||||
| Anti-RALY antibody (71-120 aa) (STJ95362) | Anmelden | Anti-RALY antibody (71-120 aa) (STJ95362) | ||||||||||||||||
|
||||||||||||||||||
| Anti-VTN antibody (209-258 aa) (STJ96249) | Anmelden | Anti-VTN antibody (209-258 aa) (STJ96249) | ||||||||||||||||
|
||||||||||||||||||
| Anti-RPS4X antibody (81-130 aa) (STJ95500) | Anmelden | Anti-RPS4X antibody (81-130 aa) (STJ95500) | ||||||||||||||||
|
||||||||||||||||||
| Anti-RPS4Y1 antibody (214-263 aa) (STJ95501) | Anmelden | Anti-RPS4Y1 antibody (214-263 aa) (STJ95501) | ||||||||||||||||
|
||||||||||||||||||
| Anti-RPS2 antibody (244-293 aa) (STJ95493) | Anmelden | Anti-RPS2 antibody (244-293 aa) (STJ95493) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SSB antibody (341-390 aa) (STJ95790) | Anmelden | Anti-SSB antibody (341-390 aa) (STJ95790) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SARS-CoV-2 Spike RBD antibody (332-550) (STJ11101792) | Anmelden | Anti-SARS-CoV-2 Spike RBD antibody (332-550) (STJ11101792) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SARS-CoV-2 Spike S1 antibody (11-682) (STJ11101793) | Anmelden | Anti-SARS-CoV-2 Spike S1 antibody (11-682) (STJ11101793) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SARS-CoV-2 Spike antibody (600-700) (STJ11101794) | Anmelden | Anti-SARS-CoV-2 Spike antibody (600-700) (STJ11101794) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SARS-CoV-2 Nucleoprotein antibody (1-420) (STJ11101492) | Anmelden | Anti-SARS-CoV-2 Nucleoprotein antibody (1-420) (STJ11101492) | ||||||||||||||||
|
||||||||||||||||||
| Anti-IMP3 antibody (135-184 aa) (STJ98644) | Anmelden | Anti-IMP3 antibody (135-184 aa) (STJ98644) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SNRPN antibody (21-70 aa) (STJ96822) | Anmelden | Anti-SNRPN antibody (21-70 aa) (STJ96822) | ||||||||||||||||
|
||||||||||||||||||
| Anti-VTN antibody (50-100 aa) (STJ97659) | Anmelden | Anti-VTN antibody (50-100 aa) (STJ97659) | ||||||||||||||||
|
||||||||||||||||||
| Anti-TNF antibody [Q34] (STJ97493) | Anmelden | Anti-TNF antibody [Q34] (STJ97493) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HNRNPU antibody [1B11-H2-B7] (STJ99127) | Anmelden | Anti-HNRNPU antibody [1B11-H2-B7] (STJ99127) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ATP6AP1 antibody (421-470 aa) (STJ99321) | Anmelden | Anti-ATP6AP1 antibody (421-470 aa) (STJ99321) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial, Biotinylated (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial, Biotinylated (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial,Biotinylated (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial,Biotinylated (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial,Biotinylated (Active) | Anmelden | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial,Biotinylated (Active) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Novel Coronavirus Spike glycoprotein(S),partial (Active) | Anmelden | Recombinant Human Novel Coronavirus Spike glycoprotein(S),partial (Active) | ||||||||||||||||
|
||||||||||||||||||





